Effectiveness, safety, and patient‐reported outcomes of emtricitabine/tenofovir alafenamide‐based regimens for the treatment of HIV‐1 infection: Final 24‐month results from the prospective German TAFNES cohort study.
Saved in:
| Title: | Effectiveness, safety, and patient‐reported outcomes of emtricitabine/tenofovir alafenamide‐based regimens for the treatment of HIV‐1 infection: Final 24‐month results from the prospective German TAFNES cohort study. |
|---|---|
| Authors: | Stephan, Christoph1 c.stephan@em.uni-frankfurt.de, Spinner, Christoph D.2, Rieke, Ansgar3, Christensen, Stefan4,5, Mauss, Stefan6, Schreiber, Sandra7, Albuquerque, Boris7, Heinzkill, Marion7, Ramroth, Heribert8, Stellbrink, Hans‐Jürgen9 |
| Source: | HIV Medicine. Feb2025, Vol. 26 Issue 2, p239-251. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14642662 |
|---|---|
| DOI: | 10.1111/hiv.13728 |
